RADICAVA is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Mitsubishi Tanabe Pharma America, Inc.. The primary component is Edaravone.
| Product ID | 70510-2171_26a8730f-518e-40d1-b695-536526c6a87b |
| NDC | 70510-2171 |
| Product Type | Human Prescription Drug |
| Proprietary Name | RADICAVA |
| Generic Name | Edaravone |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2017-05-05 |
| Marketing Category | NDA / NDA |
| Application Number | NDA209176 |
| Labeler Name | Mitsubishi Tanabe Pharma America, Inc. |
| Substance Name | EDARAVONE |
| Active Ingredient Strength | 30 mg/100mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2017-05-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA209176 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-05-05 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-03-12 |
| Marketing Category | NDA |
| Application Number | NDA209176 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-05-05 |
| Marketing Category | NDA |
| Application Number | NDA209176 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-05-05 |
| Marketing End Date | 2017-11-14 |
| Ingredient | Strength |
|---|---|
| EDARAVONE | 30 mg/100mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 70510-2171 | RADICAVA | EDARAVONE |
| 70510-2172 | RADICAVA | edaravone |
| 70510-2321 | RADICAVA ORS | EDARAVONE |
| 70510-2322 | RADICAVA ORS | EDARAVONE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RADICAVA 87132086 5387607 Live/Registered |
Mitsubishi Tanabe Pharma Corporation 2016-08-09 |
![]() RADICAVA 86863296 5277200 Live/Registered |
Mitsubishi Tanabe Pharma Corporation 2015-12-31 |